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Introduction
Organophosphorous (OP) pesticides, a 
widely used class of insecticides, have been 
the subject of concern in recent years because 
of their potential for developmental and 
neurobehavioral toxicity (Bouchard et al. 
2011; Engel et al. 2011; Rauh et al. 2011). 
Two common OP pesticides, chlorpyrifos and 
diazinon, were removed from residential pesti-
cide use between 2001 and 2004, largely due 
to concerns about effects on health (U.S. EPA 
2001); however, applications in agriculture 
continue. Although use of OP pesticides has 
declined substantially in recent years, they still 
accounted for 35% of insecticides applied in 
the United States in 2007, the latest year for 
which data are available (Grube et al. 2011).
Several OP pesticides have been associated 
with reduced fetal growth in rodent studies 
(Breslin et al. 1996; Qiao et al. 2002; Spyker 
and Avery 1977; Srivastava and Raizada 1996), 
but studies in humans are inconsistent. Two 
studies have examined maternal or fetal blood 
concentrations of OP pesticides (Barr et al. 
2010; Whyatt et al. 2004), and four studies 
have looked at maternal urinary concentra-
tions of OP metabolites (Eskenazi et al. 
2004; Rauch et al. 2012; Wang et al. 2012; 
Wolff et al. 2007). Chlorpyrifos concentra-
tions in umbilical cord blood were inversely 
associated with birth weight and length in a 
population of low-income, African-American 
and Dominican women in New York City 
recruited before the household ban (Columbia 
cohort) (Whyatt et al. 2004). However, a 
similar study conducted after the ban found 
no associations with birth outcome among 
pregnant women in New Jersey whose chlor-
pyrifos concentrations were considerably lower 
than the Columbia study (Barr et al. 2010). 
Dialkyl phosphate (DAP) metabolites of OP 
pesticides in maternal urine were inversely 
associated with infant head circumference but 
not birth weight or length in a racially and 
economically diverse population of women in 
New York City (Mount Sinai cohort) (Wolff 
et al. 2007). Prenatal urinary DAP metabo-
lites were associated with shorter length of 
gestation and nonsignificantly increased 
birth weight, length, and head circumference 
in a cohort of low-income predominantly 
Mexican women in California (Center for the 
Health Assessment of Mothers and Children 
of Salinas; CHAMACOS cohort) (Eskenazi 
et al. 2004). A study of pregnant women in 
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Background: Organophosphorous (OP) pesticides are associated with reduced fetal growth in 
animals, but human studies are inconsistent.
oBjectives: We pooled data from four cohorts to examine associations of prenatal OP exposure 
with birth weight (n = 1,169), length (n = 1,152), and head circumference (n = 1,143).
Methods: Data were from the CHAMACOS, HOME, Columbia, and Mount Sinai birth cohorts. 
Concentrations of three diethyl phosphate (ΣDEP) and three dimethyl phosphate (ΣDMP) 
metabolites of OP pesticides [summed to six dialkyl phosphates (ΣDAPs)] were measured in 
maternal urine. Linear regression and mixed-effects models were used to examine associations with 
birth outcomes.
results: We found no significant associations of ΣDEP, ΣDMP, or ΣDAPs with birth weight, 
length, or head circumference overall. However, among non-Hispanic black women, increasing 
urinary ΣDAP and ΣDMP concentrations were associated with decreased birth length (β = –0.4 cm; 
95% CI: –0.9, 0.0 and β = –0.4 cm; 95% CI: –0.8, 0.0, respectively, for each 10-fold increase 
in metabolite concentration). Among infants with the PON1192RR genotype, ΣDAP and ΣDMP 
were negatively associated with length (β = –0.4 cm; 95% CI: –0.9, 0.0 and β = –0.5 cm; 95% CI: 
–0.9, –0.1).
conclusions: This study confirms previously reported associations of prenatal OP exposure 
among black women with decreased infant size at birth, but finds no evidence of smaller birth 
weight, length, or head circumference among whites or Hispanics. Contrary to our hypothesis, we 
found stronger inverse associations of DAPs and birth outcome in infants with the less susceptible 
PON1192RR genotype. The large pooled data set facilitated exploration of interactions by race/
ethnicity and PON1 genotype, but was limited by differences in study populations.
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Rauh VA, Yolton K, Hornung RW, Wetmur JG, Chen J, Holland NT, Barr DB, Perera FP, 
Wolff MS. 2016. Prenatal exposure to organophosphorous pesticides and fetal growth: pooled 
results from four longitudinal birth cohort studies. Environ Health Perspect 124:1084–1092; 
http://dx.doi.org/10.1289/ehp.1409362
OP pesticide exposure and fetal growth
Environmental Health Perspectives • volume 124 | number 7 | July 2016 1085
Cincinnati, Ohio (Health Outcomes and 
Measures of the Environment; HOME study) 
found that prenatal urinary DAPs were associ-
ated with decreased birth weight in African-
American mothers and shorter length of 
gestation in white mothers (Rauch et al. 2012). 
However, a study in Shanghai, China, found 
no association between maternal urinary DAPs 
at time of labor and birth weight or length 
(Wang et al. 2012).
Inconsistencies in these findings may 
be attributable to differences in timing 
of exposure (e.g., early vs. late pregnancy), 
measurement of OP exposure (e.g., parent 
compounds in blood vs. nonspecific DAP 
metabolites in urine), variability in OP 
mixtures (e.g., chlorpyrifos or diazinon 
used residentially vs. a wider range of OP 
compounds used in agriculture), and patterns 
of exposure (residential vs. agricultural vs. 
dietary exposure) across studies. Other chal-
lenges to integrating these disparate results 
include the diverse racial/ethnic compositions 
of these cohorts, which contribute to differing 
frequencies of key genetic modifiers, among 
other sources of heightened susceptibility. For 
example, paraoxonase (PON) is an enzyme 
that plays a key role in metabolism and detoxi-
fication of some OP pesticides (Costa et al. 
2008). Paraoxonase levels and efficiency are 
influenced by several common single nucleo-
tide polymorphisms (SNPs) in the PON1 
gene whose allele frequencies vary significantly 
in different racial groups (Costa et al. 2003). 
SNPs at the –108 position in the promoter 
region of the PON1 gene appear to influence 
an individual’s quantity of the paraoxonase 
enzyme (subjects with PON1–108TT genotype 
have approximately 20% less paraoxonase 
enzyme), whereas SNPs at the 192 position in 
the coding region affect the catalytic efficiency 
of that enzyme in detoxifying OP pesticides 
with PON192QQ coding for the enzyme with 
the lowest efficiency (Costa et al. 2003).
To explore relationships between prenatal 
OP exposure and birth outcomes and 
potential modification by the PON1 genotype 
and race/ethnicity, we pooled data from four 
previously published longitudinal studies—
the CHAMACOS, HOME, Columbia, and 
Mount Sinai cohorts. We hypothesized that 
DAP metabolites would be inversely associ-
ated with fetal growth, and that this effect 
would be especially prominent in infants with 
the susceptible PON1 genotypes with lower 
enzyme concentration and catalytic efficiency.
Methods
The study sample combined participants from 
cohorts that measured urinary DAP metabo-
lites during pregnancy. DAP concentrations 
from the CHAMACOS, HOME, and Mount 
Sinai cohorts have been previously reported 
(Eskenazi et al. 2004; Rauch et al. 2012; 
Wolff et al. 2007). DAP concentrations were 
measured on only a subset of the Columbia 
cohort and have not been published elsewhere. 
These four studies were conducted using 
similar methods, with some key differences 
(Table 1). The CHAMACOS study enrolled 
low-income women between 1999 and 2000 
through prenatal clinics serving the farm-
worker population of the agricultural Salinas 
Valley, California (Eskenazi et al. 2004). 
Women were enrolled into the HOME 
study though prenatal clinics in metropolitan 
Cincinnati between 2003 and 2006 (Rauch 
et al. 2012). The Columbia cohort enrolled 
African-American and Dominican pregnant 
women living in northern Manhattan or 
the South Bronx between 1998 and 2006 
(Perera et al. 2003; Whyatt et al. 2004), and 
the Mount Sinai cohort enrolled an ethni-
cally diverse population of primiparous 
women receiving prenatal care at Mount Sinai 
Hospital in lower Manhattan between 1998 
and 2002 (Berkowitz et al. 2004; Wolff et al. 
2007). Major differences between the cohorts 
were the geographic, racial/ethnic, and socio-
economic characteristics of the populations. 
Mount Sinai was the only cohort limited 
to primiparous women. Additionally, the 
CHAMACOS and HOME cohorts enrolled 
participants before 20 weeks gestation and 
obtained two urinary DAP measures (early 
and late pregnancy), whereas Mount Sinai and 
Columbia obtained a single DAP measure in 
the third trimester. In all four cohorts, partici-
pants were at least 18 years of age and started 
prenatal care before 26 weeks gestation.
For the main analysis, we excluded women 
with hypertension, diabetes, and other preg-
nancy complications that might affect fetal 
growth; twins and multiple births; stillbirths 
and neonatal deaths; and women providing 
urine samples that were dilute (< 10 mg/dL 
creatinine). The pooled data set included 1,235 
women with urinary DAP measures during 
pregnancy and birth outcome data from each 
cohort: 484 women from the CHAMACOS 
study, 328 women from the HOME study, 82 
women from Columbia, and 341 women from 
Mount Sinai. Informed consent was obtained 
from all women, and study procedures were 
approved by the institutional review boards at 
each research institution.
Data Collection
In each cohort, mothers were interviewed 
during pregnancy in their preferred language 
(English or Spanish). Data collected in 
common across the four cohorts included 
demographic information (age, marital status, 
race, ethnicity, country of birth, educational 
attainment), behavioral factors (smoking, 
alcohol, drug use during pregnancy), and 
pregnancy health (parity, prenatal care use, 
pregnancy complications). Household income 
was not collected in one cohort (Mount 
Sinai) and thus could not be included in the 
pooled data set; because maternal education 
level was collected in all cohorts, it was used 
as a proxy for socioeconomic status.
Infant weight, length, and head circum-
ference at birth were abstracted from medical 
records at each location. Gestational age at 
birth was calculated by maternal report of last 
menstrual period (HOME study) or abstracted 
Table 1. Study design of the individual cohorts.
Design element CHAMACOS HOME Columbia Mount Sinai
Study location Salinas Valley, CA Cincinnati, OH New York, NY New York, NY
Sample size n = 486 n = 344 n = 314 n = 404
Enrollment years 1999–2000 2003–2006 1998–2006 1998–2002
Mean gestational age 
at enrollment
14.1 weeks 16.1 weeks 33.3 weeks 31.8 weeks
Recruitment sites Six prenatal clinics serving 
farmworkers
Seven prenatal clinics in Cincinnati Prenatal clinics at Harlem and 
NY Presbyterian hospitals
Prenatal clinic at Mt. Sinai 
Hospital
Eligibility criteria • ≥ 18 years old
• < 20 weeks gestation
• English or Spanish speaking
• Low income (Medicaid eligible)
• ≥ 18 years old
• < 19 weeks gestation
• Living in 5 surrounding counties
• Living in home built before 1978
• HIV negative
• 18–35 years old
• African-American or Dominican 
identity
• Living in Northern Manhattan or 
South Bronx at least 1 year
• First prenatal visit < 20 weeks
• No tobacco or drug use in pregnancy
• No chronic medical conditions (HIV, 
diabetes, hypertension)
• ≥ 18 years old
• Primiparous 
• First prenatal visit ≤ 26 weeks
• No alcohol or drug use in 
pregnancy
• Singleton birth
• No chronic medical conditions 
(diabetes, hypertension) or 
pregnancy complications
Race/ethnicity Mexican Various African American and Dominican Various
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from medical records (CHAMACOS, 
Columbia, Mount Sinai). Because Columbia 
and Mount Sinai measured OP exposure in a 
late stage of pregnancy, there was a truncated 
range in gestational age outcomes and few 
preterm births in these cohorts, limiting power 
to detect associations with gestational duration. 
Thus, gestational age at birth was examined as 
a covariate in the models of fetal growth, but 
not as an outcome in the pooled analyses.
Organophosphorous Pesticide 
Exposure
In each cohort, spot urine samples were 
collected from pregnant women at the time 
of interview. This included two urine samples 
from women in the CHAMACOS (mean, 
13.9 and 26.5 weeks gestation) and HOME 
(mean, 15.9 and 26.4 weeks gestation) 
cohorts and one urine collection from women 
in the Columbia (mean, 33.3 weeks gesta-
tion) and Mount Sinai (mean, 31.8 weeks 
gestation) cohorts. All urinary DAP measure-
ments were conducted by the same labora-
tory at the Center for Disease Control and 
Prevention using gas chromatography–
tandem mass spectrometry (GC-MS/MS) 
and quantified using isotope dilution cali-
bration (Bravo et al. 2002). Limits of detec-
tion (LODs) varied among the centers and 
ranged from 0.1 to 0.7 μg/L (see Table S1). 
Six individual DAP metabolites were quan-
tified: three dimethyl phosphate (DMP) 
metabolites (dimethylphosphate, dimethyl-
thiophosphate, dimethyldithiophosphate), 
derived from OP pesticides such as malathion 
and dimethoate; and three diethyl phosphate 
(DEP) metabolites (diethylphosphate, dieth-
ylthiophosphate, diethyldithiophosphate), 
derived from OP pesticides such as chlorpy-
rifos and diazinon. These DAP metabolites, 
in units of nanomoles per liter, were summed 
to yield ΣDMP, ΣDEP, and total ΣDAP for 
each individual. Many women had concen-
trations below the LOD for one or more of 
the metabolites, but only 25 women (2.1%) 
were below the LOD on all 6 metabolites (see 
Table S1). In cases where individual metabo-
lite concentrations were below the LOD, the 
machine-read value was used if available or, 
if not, a non-zero, random number below 
the LOD was substituted before the indi-
vidual DAPs were summed. The random 
values were selected from all values below the 
LOD using log-normal probability distribu-
tions whose cohort-specific parameters were 
obtained by maximum likelihood estimation 
(Lubin et al. 2004). Summed concentrations 
(ΣDMP, ΣDEP, and ΣDAP) were truncated 
at 3 standard deviations below the geometric 
mean of the pooled data set to avoid influ-
entially low values. Creatinine concentra-
tions in urine, measured using commercially 
available diagnostic enzyme methods, 
were used to account for urinary dilution. 
Creatinine-corrected ΣDMP, ΣDEP, and 
ΣDAP concentrations were log10-transformed 
for analysis. For the Columbia and Mount 
Sinai cohorts, the results of the single urinary 
measurements were used; for the HOME and 
CHAMACOS studies, the two measurements 
during pregnancy were averaged. The correla-
tions between the two ΣDAP concentrations 
during pregnancy were 0.16 and 0.25 for 
CHAMACOS and HOME, respectively.
PON1 Genotype
PON1192 and PON1–108 genotyping was 
conducted separately at each research center 
using polymerase chain reaction (PCR)–based 
methods using umbilical cord blood for 
children and maternal blood. Genotyping 
methods have been previously published for 
the CHAMACOS cohort (Holland et al. 
2006), the HOME Study (Rauch et al. 
2012), and the Mount Sinai cohort (Chen 
et al. 2003). Mothers and children were 
genotyped as QQ, QR, or RR for PON1192 
and TT, CT, or TT for PON1–108. Maternal 
PON1–108 genotype was not available from 
the HOME study, and maternal PON1192 
genotype was not available from the HOME 
or Columbia cohorts.
Data Analysis
We first compared demographic character-
istics and urinary metabolite concentrations 
across the four cohorts. We examined the 
associations of urinary ΣDAP, ΣDEP, and 
ΣDMP concentrations with infant birth 
weight, length, and head circumference in 
the pooled data set using multivariable linear 
regression. We evaluated effect modification 
by cohort and performed analyses adjusted 
for and stratified by cohort. We fit mixed-
effects models with random slope and inter-
cept, allowing for different associations in 
each cohort, and with random intercept only. 
Mixed-effects model estimates for associations 
between DAP metabolites and the outcomes 
were similar to estimates from models that did 
not include random effects for cohort (data 
not shown), and mixed-effects models did not 
have significantly better performance based on 
likelihood ratio tests (α = 0.05), so estimates 
from mixed-effects models are not reported.
Creatinine-corrected, urinary DAP 
metabolites were considered as continuous 
(log10 transformed) variables. All models 
controlled for cohort, sex, self-identified race/
ethnicity [non-Hispanic white, non-Hispanic 
black, Hispanic (regardless of race), and 
other], country of origin (USA vs. other), 
maternal education (< high school vs. ≥ high 
school), parity (primiparous vs. multipa-
rous), smoking during pregnancy (yes vs. 
no), marital status (married/living together 
vs. other), and maternal age (continuous) 
(Table 2). Covariate information was missing 
for 66 women, reducing the final sample size 
to 1,169 for birth weight, 1,152 for length, 
and 1,143 for head circumference models. 
The Hispanic category included women of 
Mexican, Puerto Rican, Dominican, and other 
Hispanic descent. To examine fetal growth 
independent of gestational age, we controlled 
for gestational age at birth using a cubic 
spline. We tested for effect modification by 
race/ethnicity, sex, maternal education, and 
child PON1192 and PON1–108 genotype by 
including cross-product interaction terms 
(e.g. for effect modification of DAPs by the 
4-level race/ethnicity variable, we constructed 
3 cross-product terms: black × DAPs, 
Hispanic × DAPs, other × DAPs). We 
compared models with and without the cross-
product terms using Wald tests to examine 
overall categories of each potential modifier 
rather than category-by-category tests of 
interaction. We considered inter action to be 
statistically significant at α = 0.1. Stratified 
analyses were conducted according to cohort, 
race/ethnicity, and maternal and child 
PON1 genotype using separate models to 
obtain stratum-specific estimates. Because of 
the small size, the race/ethnicity category of 
“other” was omitted from stratified models, 
although it was included in the models with 
interaction terms. PON1 genotype was the 
most commonly missing variable, so the 
sample size was reduced for these inter-
action models (n = 947–953 for infant and 
n = 736–804 for maternal genotype).
After constructing final models, we 
conducted sensitivity analyses including 
a) limiting analyses to nulliparous women, 
b) limiting to term births, c) treating values 
< LOD as LOD divided by the square root 
of 2, d) classifying women identifying as 
Hispanic black (e.g. Dominicans) as black 
rather than Hispanic, e) including women 
with pregnancy complications such as 
hypertension and diabetes, f) using DAP 
concentrations that were not corrected for 
creatinine, and g) using only one (late preg-
nancy) DAP measurement from the HOME 
and CHAMACOS cohorts. All analyses were 
conducted in Stata 13.
Results
The four cohorts differed on every character-
istic measured, including racial/ethnic compo-
sition, country of origin, maternal education, 
and marital status (Table 2). The Columbia 
cohort was exclusively African American and 
Hispanic (Dominican); the CHAMACOS 
cohort predominantly Hispanic (Mexican); 
the Mount Sinai cohort racially diverse, but 
predominantly Hispanic (Puerto Rican); 
and the HOME study cohort largely white. 
Educational attainment was lowest in the 
CHAMACOS cohort and highest in the 
OP pesticide exposure and fetal growth
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HOME study (21% vs. 89% completing 
high school, respectively). More women were 
married or living with their partner in the 
CHAMACOS and HOME studies (~ 80%) 
than in the two New York City studies (54% 
for Mount Sinai and 22% for Columbia). In 
the Columbia study, couples were defined 
as married/living together only if they had 
lived together at least 7 years, whereas the 
other studies included all cohabiting couples. 
Concentrations of urinary metabolites of 
OP pesticides in each cohort are shown in 
Table 3 (see also Figure S1). The geometric 
mean and median levels of total DAPs were 
highest in the agricultural CHAMACOS 
population, similar in the HOME study 
and Mount Sinai populations, and lowest in 
the Columbia cohort, despite the fact that 
the HOME study was the only study to 
enroll participants after the residential ban 
on chlorpyrifos (a DEP pesticide). The total 
DAP concentrations are dominated by DMP 
metabolites, with concentrations of DMP 
metabolites about three to four times greater 
than DEP metabolites.
No associations were seen between total 
urinary ΣDAP, ΣDEP, or ΣDMP and birth 
Table 2. Participant characteristics of the individual cohorts and pooled data set.
Characteristic
Pooled CHAMACOS HOME Columbia Mount Sinai
p-Valuean Mean ± SD or % n Mean ± SD or % n Mean ± SD or % n Mean ± SD or % n Mean ± SD or %
Gestational age (weeks) 1,235 39.1 ± 1.6 484 38.9 ± 1.7 328 39.2 ± 1.5 82 39.4 ± 1.3 341 39.3 ± 1.5 < 0.01
Birth weight (g) 1,235 3385.0 ± 514.1 484 3449.7 ± 516.4 328 3407.0 ± 566.3 82 3417.0 ± 470.9 341 3264.1 ± 444.9 < 0.01
Length (cm) 1,218 50.6 ± 2.6 478 50.2 ± 2.7 321 51.0 ± 2.8 80 50.9 ± 2.4 339 50.7 ± 2.3 < 0.01
Head circumference (cm) 1,209 34.0 ± 1.6 468 34.1 ± 1.5 322 34.3 ± 1.8 79 34.0 ± 1.5 340 33.8 ± 1.6 < 0.01
Maternal age (years) 1,235 25.9 ± 5.9 484 25.9 ± 5.0 328 28.8 ± 5.6 82 24.1 ± 5.1 341 23.4 ± 6.2 < 0.01
Prepregnancy BMI (kg/m2) 1,215 25.6 ± 5.5 484 26.9 ± 5.1 313 26.0 ± 6.3 77 26.0 ± 5.8 341 23.3 ± 4.4 < 0.01
Pregnancy weight gain (lb) 1,186 32.3 ± 15.3 481 30.0 ± 12.4 324 27.1 ± 13.7 78 37.0 ± 16.9 303 40.2 ± 17.1 < 0.01
Child sex
Male 617 50.0 243 50.2 149 45.4 34 41.5 191 56.0 0.02
Female 618 50.0 241 49.8 179 54.6 48 58.5 150 44.0
Year of birth
1998 60 4.9 0 0.0 0 0.0 0 0.0 60 17.6 < 0.01
1999 123 10.0 0 0.0 0 0.0 0 0.0 123 36.1
2000 466 37.7 308 63.6 0 0.0 35 42.7 123 36.1
2001 258 20.9 176 36.4 0 0.0 47 57.3 35 10.3
2003 26 2.1 0 0.0 26 7.9 0 0.0 0 0.0
2004 129 10.4 0 0.0 129 39.3 0 0.0 0 0.0
2005 122 9.9 0 0.0 122 37.2 0 0.0 0 0.0
2006 51 4.1 0 0.0 51 15.5 0 0.0 0 0.0
Maternal race/ethnicity
Non-Hispanic white 288 23.4 8 1.7 210 64.4 0 0.0 70 20.5 < 0.01
Non-Hispanic black 220 17.8 0 0.0 94 28.8 35 42.7 91 26.7
Hispanic 693 56.2 463 95.7 9 2.8 47 57.3 174 51.0
Other 32 2.6 13 2.7 13 4.0 0 0.0 6 1.8
Maternal country of origin
Other 535 45.0 416 86.0 18 5.5 37 45.1 64 21.6 < 0.01
USA 653 55.0 68 14.0 308 94.5 45 54.9 232 78.4
Maternal education
Less than high school 546 44.3 381 78.7 35 10.7 30 36.6 100 29.4 < 0.01
Completed high school 686 55.7 103 21.3 291 89.3 52 63.4 240 70.6
Marital status
Single 382 31.0 96 19.8 65 19.9 64 78.1 157 46.0 < 0.01
Married/living together 851 69.0 388 80.2 261 80.1 18 22.0 184 54.0
Parity
Nulliparous 693 56.2 162 33.5 143 43.9 47 57.3 341 100.0 < 0.01
Multiparous 540 43.8 322 66.5 183 56.1 35 42.7 0 0.0
Smoking during pregnancy
No 1,086 89.4 454 93.8 268 87.0 80 97.6 284 83.3 < 0.01
Yes 129 10.6 30 6.2 40 13.0 2 2.44 57 16.7
Child PON–108
TT 167 16.9 76 17.6 52 17.9 14 20.6 25 12.6 < 0.01
CT 453 45.8 224 52.0 113 38.8 32 47.1 84 42.2
CC 369 37.3 131 30.4 126 43.3 22 32.4 90 45.2
Child PON192
QQ 300 30.1 108 24.8 117 39.8 14 20.9 61 30.5 < 0.01
QR 450 45.2 222 51.0 115 39.1 25 37.3 88 44.0
RR 246 24.7 105 24.1 62 21.1 28 41.8 51 25.5
Maternal PON–108
TT 165 19.5 103 23.0 — 14 20.6 48 14.5 < 0.01
CT 374  44.1 218 48.7 — 31 45.6 125 37.7
CC 309 36.4 127 28.3 — 23 33.8 159 47.9
Maternal PON192
QQ 220 28.2 125 27.9 — — 95 28.6 0.76
QR 364 46.7 206 46.0 — — 158 47.6
RR 196 25.1 117 26.1 — — 79 23.8
BMI, body mass index.
ap-Values for differences across cohorts. F-tests for continuous variables, chi-square tests for categorical variables.
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weight, length, and head circumference in 
the pooled cohort (Table 4). Associations 
with 10-fold increases in urinary ΣDAP 
concentrations were close to null for birth 
weight [β = 4.47; 95% confidence interval 
(CI): –35.56, 44.49], length (β = –0.00; 
95% CI: –0.21, 0.22), and head circum-
ference (β = –0.02; 95% CI: –0.16, 0.11). 
Estimates were similar for 10-fold increase 
in ΣDEP and ΣDMP metabolites (Table 4). 
Interactions with cohort were not statistically 
significant for any of the exposures or 
outcomes (p-values ranged from 0.11 to 
0.85; Figure 1). Estimates stratified by cohort 
(Table 4 and Figure 1) were similar but not 
identical to those of previously published 
reports (Eskenazi et al. 2004; Rauch et al. 
2012; Wolff et al. 2007) in which the 
CHAMACOS cohort tended to show positive 
trends of urinary OP metabolites with fetal 
growth while the other cohorts showed 
negative or null associations. Differences from 
previously reported results were attributable 
to slight changes in exclusions, sample size, 
covariates, correction for urinary dilution, 
and substitution methods for values < LOD.
No statistically significant interaction 
(α = 0.1) was seen for race/ethnicity 
(Figure 2), sex (data not shown), or educa-
tion (data not shown). Although interaction 
by race/ethnicity was not statistically signifi-
cant, we present stratified results (Figure 2) 
for non-Hispanic white, non-Hispanic black, 
and Hispanic women (women of “other” 
race/ethnicity were dropped from the analysis 
due to small numbers) because the HOME 
study has reported differences in associations 
of DAP and birth outcome by race/ethnicity. 
We did find statistically significant inter-
action for some OP metabolites and PON1 
genotypes, so we present results stratified by 
child (Figure 3) and maternal (see Figure S2) 
PON1 genotype.
In models stratified by race/ethnicity 
(Figure 2),  higher concentrations of 
total ΣDMP were associated with lower 
infant weight (β = –66.78 g; 95% CI: 
–137.46, 3.90) and length (β = –0.40 cm; 
95% CI: –0.76, –0.04), and ΣDAP were 
associated with decreased birth length 
(β = –0.46 cm; 95% CI: –0.91, –0.01) in 
non-Hispanic black women. When Hispanic 
blacks (specifically Dominican women in the 
Columbia cohort) were classified as black 
rather than Hispanic in sensitivity analyses, 
the associations between ΣDMP and birth 
weight (β = –43.63 g; 95% CI: –97.23, 9.97) 
and length (β  = –0.23 cm; 95% CI: 
–0.51, 0.06) among blacks persisted but were 
attenuated, and negative associations were 
Table 3. Distributions of urinary metabolites of organophosphate pesticides (nmol/g creatinine) 
measured during pregnancy, by cohort and pooled.
Cohort n
Geometric 
Mean (SD) < LOD (%)
Percentile
Maximum25th 50th 75th 95th
CHAMACOSa
Total ΣDAP 484 105.63 (2.98) 0.0 50.3 102.0 220.9 697.0 3359.8
ΣDEP 484 16.41 (3.07) 0.0 7.8 16.3 34.8 100.6 453.5
ΣDMP 484 76.31 (3.63) 0.0 34.2 78.5 182.3 639.1 3228.9
HOMEa
Total ΣDAP 328 66.78 (3.52) 1.6 28.9 70.1 154.2 466.8 1715.4
ΣDEP 328 11.15 (4.47) 16.9 4.5 14.5 31.8 89.3 199.1
ΣDMP 328 44.61 (4.28) 4.8 16.5 46.4 115.1 448.3 1686.8
Columbia
Total ΣDAP 82 42.88 (7.44) 7.3 21.3 59.6 135.3 638.0 1622.8
ΣDEP 82 7.39 (13.38) 19.5 4.9 19.4 36.1 110.4 231.8
ΣDMP 82 11.36 (20.63) 25.6 2.9 29.1 110.3 445.4 1584.2
Mount Sinai
Total ΣDAP 341 75.54 (5.50) 4.1 29.5 77.9 209.0 894.7 8498.6
ΣDEP 341 12.79 (8.96) 14.4 6.9 19.4 52.9 163.1 1629.5
ΣDMP 341 41.10 (7.58) 5.6 13.3 47.3 153.9 760.4 8498.5
Pooled
Total ΣDAP 1,235 80.30 (4.14) 2.1 37.1 87.1 199.4 753.1 8498.6
ΣDEP 1,235 13.11 (5.49) 10.2 6.2 16.6 37.5 113.9 1629.5
ΣDMP 1,235 49.15 (5.94) 4.7 20.6 57.2 149.5 631.6 8498.5
Abbreviations: ΣDAP, dialkyl phosphate metabolites; ΣDEP, diethyl phosphate metabolites; ΣDMP, dimethyl phosphate 
metabolites.
aCHAMACOS and HOME urinary metabolites are the average of two pregnancy measurements. Columbia and Mount 
Sinai are a single pregnancy measure. 
Table 4. Associations of 10-fold increases in urinary metabolites of organophosphate pesticides and fetal growth, by individual cohort and pooled data set.
Cohort, metabolite 
Birth weight (g) Length (cm) Head circumference
n β (95% CI) p-Value n β (95% CI) p-Value n β (95% CI) p-Value
CHAMACOS          
Total ΣDAP 484 28.06 (–51.35, 107.46) 0.49 478 0.15 (–0.30, 0.61) 0.51 468 0.20 (–0.06, 0.46) 0.13
ΣDEP 484 66.59 (–10.09, 143.26) 0.09 478 0.22 (–0.22, 0.66) 0.32 468 0.27 (0.01, 0.52) 0.04
ΣDMP 484 16.25 (–51.31, 83.82) 0.64 478 0.10 (–0.29, 0.49) 0.62 468 0.13 (–0.10, 0.35) 0.26
HOME          
Total ΣDAP 307 –28.29 (–130.43, 73.85) 0.59 300 –0.03 (–0.55, 0.48) 0.89 301 –0.19 (–0.53, 0.14) 0.26
ΣDEP 307 –22.84 (–104.18, 58.50) 0.58 300 –0.04 (–0.44, 0.37) 0.85 301 –0.05 (–0.32, 0.22) 0.70
ΣDMP 307 –5.71 (–92.62, 81.19) 0.90 300 0.02 (–0.42, 0.45) 0.93 301 –0.16 (–0.45, 0.12) 0.27
Columbia          
Total ΣDAP 82 –10.40 (–124.30, 103.50) 0.86 80 0.07 (–0.52, 0.67) 0.80 79 –0.26 (–0.61, 0.09) 0.14
ΣDEP 82 35.11 (–52.03, 122.26) 0.42 80 0.33 (–0.13, 0.78) 0.15 79 –0.06 (–0.34, 0.21) 0.65
ΣDMP 82 –34.87 (–109.57, 39.84) 0.35 80 –0.16 (–0.55, 0.23) 0.41 79 –0.22 (–0.45, 0.02) 0.07
Mount Sinai          
Total ΣDAP 296 –0.65 (–58.07, 56.76) 0.98 294 –0.08 (–0.39, 0.23) 0.63 295 –0.08 (–0.30, 0.14) 0.47
ΣDEP 296 –37.96 (–83.11, 7.18) 0.10 294 –0.06 (–0.31, 0.18) 0.62 295 0.02 (–0.16, 0.19) 0.86
ΣDMP 296 16.21 (–32.73, 65.14) 0.52 294 –0.05 (–0.31, 0.22) 0.71 295 –0.03 (–0.22, 0.16) 0.74
Pooled          
Total ΣDAP 1,169 4.47 (–35.56, 44.49) 0.83 1,152 0.00 (–0.21, 0.22) 0.98 1,143 –0.02 (–0.16, 0.11) 0.73
ΣDEP 1,169 1.55 (–31.58, 34.67) 0.93 1,152 0.06 (–0.12, 0.24) 0.53 1,143 0.04 (–0.07, 0.15) 0.46
ΣDMP 1,169 2.96 (–29.66, 35.58) 0.86 1,152 –0.03 (–0.21, 0.15) 0.75 1,143 –0.03 (–0.14, 0.08) 0.59
Abbreviations: ΣDAP, dialkyl phosphate metabolites; ΣDEP, diethyl phosphate metabolites; ΣDMP, dimethyl phosphate metabolites. All urinary metabolites were creatinine-corrected. 
CHAMACOS and HOME urinary metabolites are the average of two pregnancy measurements. Models were adjusted for center, sex, race/ethnicity (non-Hispanic white, non-Hispanic 
black, Hispanic, other), country of origin (USA, other), marital status (married/living as married, not married/living as married), maternal education (< and ≥ high school diploma/ 
equivalent), smoking during pregnancy, parity (nulliparous and multiparous), maternal age at delivery, and gestational age (spline).
OP pesticide exposure and fetal growth
Environmental Health Perspectives • volume 124 | number 7 | July 2016 1089
also seen with ΣDMP and head circumfer-
ence (β = –0.18 cm; 95% CI: –0.37, 0.02), 
although none of the associations was 
 statistically significant.
The distribution of maternal and 
child PON1 SNPs differed among the four 
cohorts (Table 2) and was likely related to 
the differing racial/ethnic composition of the 
cohorts since PON1 allele frequencies have 
been shown to vary by race/ethnicity (Rojas-
Garcia et al. 2005). Analyses stratified by 
infant PON1–108 genotype (Figure 3), revealed 
nonsignificant negative associations of birth 
weight (β = –60.53 g; 95% CI: –123.59, 2.53) 
and ΣDEP and of length and ΣDAP 
(β = –0.33 cm; 95% CI: –0.72, 0.05), ΣDEP 
(β = –0.27 cm; 95% CI: –0.60, 0.05), and 
ΣDMP (β = –0.29 cm; 95% CI: –0.62, 0.02) 
among infants with the PON1–108CC genotype. 
In contrast, positive associations of DAPs and 
birth outcomes were seen among infants with 
the PON1–108TT genotype, including a statisti-
cally significant positive association of ΣDMP 
and length (β = 0.47 cm; 95% CI: 0.03, 0.91). 
Interaction terms for genotype × DAPs were 
statistically significant in the models of ΣDEP 
on birth weight (p = 0.08) and ΣDAP and 
ΣDMP on length (p = 0.07 and p = 0.02, 
respectively). With infant PON1192 genotype, 
we observed negative associations of length and 
ΣDAP (β = –0.42 cm; 95% CI: –0.89, 0.04; 
pinteraction = 0.25) and ΣDMP (β = –0.46 cm; 
95% CI: –0.86, –0.06; pinteraction = 0.14) 
among the RR group. Positive associations 
were seen with head circumference and 
ΣDAP (β = –0.23 cm; 95% CI: –0.02, 0.47; 
pinteraction = 0.05) and ΣDMP (β = –0.15 cm; 
95% CI: –0.03, 0.33; pinteraction = 0.11) among 
the heterozygous QR group. No statistically 
significant associations were seen for DAPs 
and birth outcome stratifying by maternal 
PON1 genotype (see Figure S2), except for 
a positive association of total ΣDEP and 
head circumference (β = 0.31 cm; 95% CI: 
0.07, 0.55; pinteraction = 0.13) in mothers 
with the PON1192QR genotype. Interaction 
terms for genotype × DAPs were statistically 
significant in the models of ΣDAP and ΣDMP 
on head circumference (p = 0.09 for both), 
again with positive associations seen in the 
heterozygous PON1192QR genotype, although 
no associations were statistically significant. 
Maternal PON1192 genotype was not avail-
able for Columbia participants, and no 
maternal PON1 genotypes were available for 
HOME participants.
In sensitivity analyses, results did not 
change substantively when the sample was 
limited to primiparous women (n = 638) 
or term births (n = 1,090) or when women 
with pregnancy complications (n = 103) 
were included (data not shown). Results were 
also similar when the DAP concentrations 
were uncorrected for creatinine, when values 
< LOD were assigned LOD divided by the 
square root of 2, and when only one late 
pregnancy measure of urinary metabolites was 
used for each woman (data not shown).
Discussion
We found no significant associations between 
metabolites of OP pesticides and birth 
weight, length, and head circumference in a 
pooled data set of > 1,000 pregnant women 
from four birth cohort studies. Animal studies 
suggest that OPs may restrict fetal growth, 
possibly by influencing the adenylyl cyclase 
signaling cascade, by increasing thyroxine 
levels, or by effects on placental transport of 
nutrients (Eskenazi et al. 1999). However, 
previously published results from these four 
birth cohorts (Eskenazi et al. 2004; Rauch 
et al. 2012; Whyatt et al. 2004; Wolff 
et al. 2007) showed associations between 
Figure 1. Association of 10-fold increase in maternal prenatal urinary total DAP, DMP, and DEP metabolites with infant birth weight (A), length (B), and head 
circumference (C) in each cohort and in the pooled data set. Models were adjusted for sex, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, 
other), country of origin (USA, other), marital status (married/living as married, single), maternal education (< high school, high school graduate), smoking during 
pregnancy, parity (nulliparous, multiparous), maternal age at delivery, and gestational age (spline). Interaction p-values from Wald tests on cross-product terms.
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Figure 2. Association of 10-fold increase in maternal prenatal urinary total DAP, DMP, and DEP metabolites with infant birth weight (A), length (B), and head 
circumference (C) in the pooled data set, stratified by race/ethnicity. Models adjusted for cohort, sex, country of origin (USA, other), marital status (married/
living as married, single), maternal education (< high school, high school graduate), smoking during pregnancy, parity (nulliparous, multiparous), maternal age at 
delivery, and gestational age (spline). Participants of “other” race/ethnicity not included in figure. Interaction p-values from Wald tests on cross-product terms.
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OP exposure and birth outcome that were 
inconsistent across studies. However, we 
did observe inverse associations of DAP 
and DM metabolites with birth length and 
nonsignificant inverse associations of DM 
metabolites with birth weight among black 
women. This is consistent with findings of 
decreased birth weight with increasing DAP, 
DE, and DM concentrations among black 
women in the HOME study (Rauch et al. 
2012) and decreased birth weight and length 
with increasing blood concentrations of chlor-
pyrifos in African-American and Dominican 
women in the Columbia study (Whyatt 
et al. 2004)—although it should be noted 
that chlorpyrifos devolves to DEP metabolites 
(Bravo et al. 2002), and the main association 
seen in blacks in this study was with DMPs.
We hypothesized that we might see 
inverse associations of urinary OP metabolites 
with birth outcomes in mothers or children 
with the more vulnerable PON1–108TT and 
PON1192QQ genotypes. In the Mount Sinai 
cohort, DEP metabolites were associated 
with significantly lower birth weight among 
mothers with the PON1192QQ genotype 
(Wolff et al. 2007). In the CHAMACOS 
study, the inverse associations of DAPs with 
gestational duration were strongest among 
infants with PON1–108TT and PON1192QQ 
genotypes (Harley et al. 2011). However, this 
pattern was not seen in the HOME cohort, 
where decrements in birth weight and gesta-
tional age associated with DAP were greatest 
among infants with heterozygous PON1–108CT 
and PON1192QR genotypes (Rauch et al. 
2012). In the pooled analysis, birth weight 
was negatively associated with total DEPs in 
infants with the PON1–108CC genotype, and 
birth length was negatively associated with 
both DAP and DMP metabolites among 
infants with the PON1–108CC and PON1192RR 
genotypes, rather than the less active 
PON1–108TT and PON1192QQ genotypes, as 
hypothesized. We found limited interaction 
of DAPs with maternal PON1 genotype, and 
the patterns of association did not support 
stronger negative associations among women 
with the more susceptible genotypes, even 
though maternal genotype might be hypoth-
esized to be the more powerful determinant of 
susceptibility than infant genotype given that 
mothers have approximately four times the 
paraoxonase enzyme as newborns and have a 
50% overlap with infant genotype (Holland 
et al. 2006). We had fewer observations 
for the maternal genotype analysis because 
HOME study participants did not have 
maternal genotype data for either SNP, and 
Columbia study participants had data for only 
one; however, there was little or no evidence 
of consistent patterns of association, as might 
be expected if the only issue was reduced 
precision. Thus, it is possible that the patterns 
with infant genotype were attributable to 
chance. An additional issue is that PON1 allele 
frequencies vary by race/ethnicity, as can be 
seen in the different SNP distributions across 
cohorts. Because race/ethnicity is associated 
with birth outcome and PON1 genotype and 
may also be associated with OP exposure, 
confounding by race/ethnicity is a possibility. 
Although we controlled for race/ethnicity 
in the models, there is considerable genetic 
variability within race/ethnicity categories 
(perhaps especially among the Hispanic 
category, which included women of Mexican, 
Puerto Rican, and Dominican origin), 
suggesting that we cannot completely discount 
the possibility of residual confounding.
In addition to racial and ethnic differ-
ences, the cohorts also varied in sources and 
routes of OP pesticide exposures, including 
food, home pesticide use, and agricultural 
drift or take-home exposure. Thus, urinary 
DAP concentrations may reflect different 
exposures in each cohort, limiting their 
interpretation in the pooled data set. In 
the farmworker CHAMACOS population, 
urinary DAPs likely represented a combina-
tion of agricultural, residential, and dietary 
exposure, a different mix of pesticides than 
would be experienced by the low-income, 
urban Columbia and Mount Sinai popula-
tions who were presumably exposed only 
through residential and dietary routes, or 
the more affluent HOME study participants 
who were enrolled after the residential ban 
and likely exposed mainly through diet. 
The HOME participants had relatively high 
DAP levels considering that their exposure 
was mainly dietary, suggesting that they may 
Figure 3. Association of 10-fold increase in maternal prenatal urinary total DAP, DMP, and DEP metabolites with infant birth weight, length, and head circumfer-
ence in the pooled data set, stratified by infant PON–108 genotype (A–C) and infant PON192 genotype (D–F). Models adjusted for cohort, sex, race/ethnicity (non-
Hispanic white, non-Hispanic black, Hispanic, other), country of origin (USA, other), marital status (married/living as married, single), maternal education (< high 
school, high school graduate), smoking during pregnancy, parity (nulliparous, multiparous), maternal age at delivery, and gestational age (spline). Interaction 
p-values from Wald tests on cross-product terms.
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have had higher fruit and vegetable consump-
tion, a very different route of exposure than 
women who may be exposed from home 
pesticide use.
Not all of the six urinary DAPs were 
equally detected. The proportion of women 
with values below the detection limit in the 
pooled sample ranged from 9% for DMTP 
to 78% for DEDTP. Individual OPs do 
not necessarily devolve to all three DE or 
DM metabolites—for example, malathion 
devolves to DMP, DMTP (dimethylthio-
phosphate), and DMDTP (dimethyldithio-
phosphate), whereas oxydemeton-methyl 
devolves only to DMP and DMTP (Bravo 
et al. 2002)—and it is expected that certain 
metabolites have lower detection frequencies 
than others. For this reason, we examined 
ΣDEP and ΣDMP metabolites to obtain 
comprehensive estimates of exposure to 
all DE- and DM-devolving OP pesticides. 
However, the large number of women with 
concentrations < LOD for some metabo-
lites may have resulted in minor misclassi-
fication at the very lowest exposure levels. 
Misclassification of these minimal exposures 
would not be expected to seriously bias the 
exposure–response estimation across the full 
range of exposure.
Although urinary DAPs are a useful 
biomarker of OP pesticide exposure, they 
have limitations. OPs have short half-lives 
in the body and show considerable intra-
individual variability over time; thus, urinary 
DAPs represent short-term rather than 
ongoing exposure. DAPs are non specific 
metabolites, and not all pesticides that 
devolve to the same metabolite are equally 
toxic; for example, both oxydemeton-methyl 
and malathion devolve to DMP metabolites, 
but the former is much more toxic (U.S. EPA 
2002). Although we can determine whether 
the parent pesticide was from the DEP or 
DMP class, we cannot determine the mix of 
actual pesticide parent compounds to which 
the mother was exposed. Thus, we cannot 
examine how the toxicity of the pesticide 
mixture differed across cohorts. Additionally, 
OPs can break down to DAPs in the envi-
ronment as well as in the body, so DAP 
concentrations in urine reflect a mixture of 
exposure to toxic parent compounds and 
nontoxic preformed DAPs in dust and food 
(Quirós-Alcalá et al. 2012). The proportion 
of preformed DAPs may be greater in popula-
tions receiving their exposure predominantly 
from food, where the parent pesticide has 
had more time to break down into DAPs 
before consumption. Finally, although DAP 
concentrations were all measured in the same 
laboratory using the same analytical methods, 
samples were stored for different amounts 
of time and analysis took place in different 
years. Thus, we cannot rule out the possibility 
of storage or batch effects, suggesting that, 
although rank order of DAP concentrations is 
internally consistent within cohort, rank may 
not be accurate when DAP concentrations 
measured in different batches (i.e. cohorts) are 
pooled together.
One strength of this study is its large 
sample size, which allows for better examina-
tion of race/ethnicity and genetic variability 
than in the more homogenous, individual 
cohorts. Methodologies were similar between 
cohorts and tests of interaction by cohort 
failed to reject the hypothesis of homogeneity 
by cohort. Analyses in our pooled cohort 
confirmed earlier findings of associations of 
OP exposure (as measured by DAPs in urine 
and chlorpyrifos in blood) with decreased 
birth weight in non-Hispanic black women, 
but not in whites or Hispanics (Rauch et al. 
2012; Whyatt et al. 2004). In general, non-
Hispanic black women had a wider range 
and more variability in birth weight, which 
may explain why an association was seen in 
this group.
Overall, this study does not support 
associations of OP pesticide exposure during 
pregnancy with decreased weight, length, 
or head circumference at birth, except in 
black women and possibly infants with the 
PON1–108CC and PON1192RR genotypes. 
However, this study also illustrates the limita-
tions of pooling data when the population 
demographics and exposure patterns for 
biomarkers of exposure with a short half-life 
differ across cohorts. Although pooling data 
from multiple cohorts is tempting, careful 
consideration must be given to the interpreta-
tion of the exposure measures in each cohort 
and whether rank order is maintained and 
remains meaningful across the pooled cohort. 
In some cases, individual cohort studies with 
homogeneous populations may be preferable 
to pooled data.
Editor’s Note: In the Advance Publication, the 
symbols in the figure legends for Figures 2 and 3 
were incorrect. In the Figure 2A–C legends, 
the correct symbols are triangles to indicate 
“Non-Hispanic Black” and circles to indicate 
“Hispanic.” In the Figure 3A–C legends, the 
correct symbols are triangles to indicate “CT” 
and circles to indicate “CC.” In the Figure 
3D–F legends, the correct symbols are triangles 
to indicate “QR” and circles to indicate “RR.” 
The correct figure legends are included in 
this article.
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